WST — West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on NYSE. It is led by Eric M. Green, based in 530 Herman O. West Drive, Exton, PA, United States, 19341-1147, with about 10,600 employees. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Latest reported WST revenue for 2025-09-30 was $804.6M. Net income was $140.0M. Revenue was up 5.0% from 2025-06-30 to 2025-09-30. WST currently screens at market cap $15.97B and trailing P/E 34.8.

Use this WST page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the WST quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the WST SEC filings page. Lician reads the product cache first so this HTML stays unique to West Pharmaceutical Services Inc even when a live quote feed is slow.